← Back to patent-cliff list
Panosyl-isomaltooligosaccharide
Tier C — Watch / tradePanosyl-isomaltooligosaccharide
Microbiome
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：Gastro-oesophageal reflux disease
Regional status
US
Phase II
2023-03-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Panosyl-isomaltooligosaccharide?
Approved indications include: Gastro-oesophageal reflux disease.
When does the Panosyl-isomaltooligosaccharide patent expire?
No public expiry year is available for Panosyl-isomaltooligosaccharide yet; this page updates once verified.
How do I get a quote for Panosyl-isomaltooligosaccharide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03